83 reports

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017

79 pages • By Delve Insight

DelveInsight’s, “Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017” discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic...

1 318 1 450 1 120
Mar 2017

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022

120 pages • By Kuick Research

“Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022” report gives comprehensive insight on clinical and non-clinical issues involved with growth of global biosimilar insulin market. This report analyzes various aspects like rationale design of insulin molecule, mechanism of insulin in diabetes, engineering of synthetic...

1 364 1 500 1 159
Feb 2017

Generic Drugs Market Forecast 2017-2027

304 pages • By Visiongain

Report Details The generic drugs market is expected to grow at a CAGR of 8.8% in the first half of the forecast period and CAGR of 7.0% in the second half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2015 to 2027. The market is estimated at $254.6bn in 2016, $384.0bn in 2021, and $574.7bn in 2027. How...

2 799 3 135 2 491
Jan 2017

Fumarate De Formoterol -Drug Insights, 2017

By Delve Insight

DelveInsight Drug Report, “Fumarate De Formoterol- Drug Insights, 2017” highlights the Fumarate De Formoterol marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Fumarate De Formoterol covering the total sales estimation and also provides...

909 1 000 773
Jan 2017

Fumarate De Formoterol-API Insights, 2017

By Delve Insight

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the...

455 500 386
Jan 2017

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2017

By Delve Insight

DelveInsight’s, “Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists. The DelveInsight’s Report covers the product profiles in various stages of...

1 136 1 250 966
Jan 2017

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

154 pages • By MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application (Oncology, Blood Disorders) - Global Forecast To 2021 The global biosimilars market is expected to reach USD 10.90 billion by...

5 045 5 650 4 338
Jan 2017

Biosimilars Business Review Q4 2016

32 pages • By Espicom Business Intelligence

Industry Trend Analysis - US Biosimilar Approvals To Rise In 2017 But Interchangeability Will Hamper Progress Industry Trend Analysis - Amjevita Approval Reinforces Amgen's Biosimilar Market View Industry Brief - Cinfa Commences Second Pegfilgrastim Study Industry Trend Analysis - Shire Turns Away From Biosimilars Industry Brief...

988 1 334 820
Dec 2016

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

85 pages • By Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by 2015 sales) used in the treatment of chemotherapy-induced febrile neutropenia. These drugs, both belonging to biotech giant Amgen, fall under...

901 1 000 766
Nov 2016

Biosimilars Education: Addressing a significant unmet need

By Firstword Pharma

How to educate stakeholders about biosimilar benefits What information and data do physicians, payers and patients need about biosimilars? As the market expands and new therapeutic sectors come on stream, more stakeholders will come into contact with biosimilars. Their information needs vary widely from a basic understanding...

2 225 2 448 1 647
Nov 2016

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)

58 pages • By Daedal Research

Scope of the Report The report entitled “Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)”, provides an analysis of global biosimilar market in terms of value. The report also provides a brief analysis of the global biologics market by value and market share by products. Furthermore, the report also assesses...

727 800 618
Nov 2016

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

177 pages • By Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

1 227 1 350 1 043
Oct 2016

Insulin Biosimilars - Global Market Outlook (2016-2022)

153 pages • By Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing pervasiveness of type 1 diabetes and ongoing approvals by the government authorities are nurturing the market growth. Some drivers such as...

3 922 4 157 2 745
Oct 2016

Global mAb Biosimilars Market 2016-2020

103 pages • By Infiniti Research Limited

About Biosimilars Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the...

2 427 2 500 2 087
Sep 2016

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

146 pages • By Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, growing prevalence of chronic diseases among aging population are the prime growth drivers of global remicade biosimilar market. In addition,...

4 773 5 250 4 057
Sep 2016

Global Biosimilar Market Outlook 2022

135 pages • By RNCOS

A biosimilar is a biologic product that is similar to a regulatory body approved reference product, and has no clinically meaningful differences in terms of safety and effectiveness from that reference product. Only minor differences in clinically inactive components are allowable in biosimilar products. The global biosimilars market is expected...

1 364 1 500 1 159
Sep 2016

Biosimilar - Global Market Outlook (2016-2022)

130 pages • By Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising...

3 922 4 157 2 745
Sep 2016

The Future of Generic Drugs and Strategies for Commercial Success

83 pages • By CBR Pharma Insights

The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies...

2 723 2 995 2 314
Sep 2016

Global Biosimilars Market 2016-2020

152 pages • By Infiniti Research Limited

About Biosimilars Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product....

2 427 2 500 2 087
Aug 2016

The Future of Biosimilars 2016

By Firstword Pharma

Development activity is surging as the focus shifts to commercialisation. How will the market evolve? The race to commercialise biosimilars is on. What will it take to create a thriving market? Will payers see real cost savings? Will developers make money? What will...

2 145 2 360 1 587
Jul 2016

Fipronil: Global Product Intelligence (2015-2020)

140 pages • By Sprout Intelligence

REPORT OBJECTIVES The report “Fipronil: Global Product Intelligence (2015-2020)” provides market intelligence on the different segments of the agrochemical, based on type of formulation, crop type, pest, and geography. Market size and forecast (2015-2020) has been provided in terms of both, Value (000 USD) and Volume (000 KG) in...

1 250 1 375 1 063
Jul 2016

Analyzing the Global Biosimilars Industry 2016

285 pages • By Aruvian's R'search

Biosimilars are the officially approved versions of biopharmaceutical products that are manufactured by a different company following the patent expiry of the original product. Also known as subsequent entry biologics or follow-on biologics, biosimilar drugs are gaining popularity around the world as the development cost of biosimilars is...

1 000 1 100 850
Jul 2016

Global Biosimilars Industry

278 pages • By Global Industry Analysts

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics...

4 091 4 500 3 477
Jul 2016

Global Generic Drugs Market 2016-2020

111 pages • By Infiniti Research Limited

About the Generic Drugs Market Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar...

2 427 2 500 2 087
May 2016

Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

70 pages • By International Market Analysis Research and Consult

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in japan was due to several reasons....

1 091 1 200 927
May 2016

US Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

72 pages • By International Market Analysis Research and Consult

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2010-2015, the US generic drug market grew at a CAGR of more than 11% and currently represents a multibillion...

1 091 1 200 927
May 2016

Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

71 pages • By International Market Analysis Research and Consult

Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population,...

1 091 1 200 927
May 2016

Generic Drugs Industry Forecasts - China Focus

63 pages • By Asia Market Information & Development Company

This study focuses on China’s Generic Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial...

909 1 000 773
May 2016

Generic Drugs Companies in China

56 pages • By Asia Market Information & Development Company

This study focuses on China’s Generic Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...

1 636 1 800 1 391
May 2016

Generic Drugs Markets in China

220 pages • By Asia Market Information & Development Company

China's demand for Generic Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for...

3 636 4 000 3 091
May 2016